First In Ventures — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Mabletrymable.com in 𝕏Seed · Jul 2022 · $3.2MAcquired

Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon, GB

Roman Rothaermel(Founder)inInna Thalmann(Founder)inChris EijsboutsinKumeren GovnderArik Keller(Founder)Eric Carlstrom(Founder)

Co-investorsInitialized Capital Underscore VC Venrock Y Combinator Arkitekt Ventures G20 Ventures +1 more

Yali Bioyalibio.com inFeb 2022 · $3.9M

Yali develops fermentation technology to produce sustainable fats and lipids for alternative dairy products like ice cream, butter, and milk, using fewer inputs than conventional sources.

BiotechCleantechClimate TechFoodTech

Co-investorsFTW Ventures S2G Investments CRCM Ventures Third Kind Venture Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.